New Therapeutic Strategies against Helicobacter pylori / 대한소화기학회지
The Korean Journal of Gastroenterology
;
: 146-150, 2014.
Artículo
en Coreano
| WPRIM
| ID: wpr-89371
ABSTRACT
The standard therapy for Helicobacter pylori infection in Korea is a triple-drug regimen consisting of a proton pump inhibitor with two antibiotics such as clarithromycin, amoxicillin, and metronidazole. However, as the eradication rate of this regimen has declined over the past decade, this prompted the formulation of new therapeutic regimens. New therapeutic strategies against H. pylori infection that had been tried all over the world include sequential therapy, concomitant therapy, and tailored therapy This article will review the basic concepts and the results of previous clinical trials on the aforementioned new therapeutic regiments.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Helicobacter pylori
/
Infecciones por Helicobacter
/
Claritromicina
/
Quimioterapia Combinada
/
Inhibidores de la Bomba de Protones
/
Erradicación de la Enfermedad
/
Amoxicilina
/
Antibacterianos
/
Nitroimidazoles
Límite:
Humanos
Idioma:
Coreano
Revista:
The Korean Journal of Gastroenterology
Año:
2014
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS